The Cooper Compan…
USUSDThe Cooper Companies, Inc (US:COO) — Ophthalmic Goods. Number of exchanges where the company shares trade: 5. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- coopercos.com
- Investor relations
- investor.coopercos.com/
- Sector
- Health Care · Ophthalmic Goods
- Headquarters
- SAN RAMON, United States
- Management
- Albert G. White
- Employees
- 15 000
- Founded
- 1958
- IPO
- 1983-01-21
- Shares outstanding
- 190.16 M as of 2026-09-03
- Free float
- 188.77 M
- Market cap
- 11.39 B USD
- Insiders
- 0.63%
- Institutions
- 111.92%
- Industry (SIC)
- Ophthalmic Goods
- Legal form
- XTIQ
- ISIN
- US2166484020
- LEI
- QJKMVPIGLH7530PCUE20
- P/EP/E (Price / Earnings) — how many years of the company's profit you pay for a share. Calculated: current price ÷ net earnings per share over the last 12 months. Lower means cheaper relative to profit. Not calculated when the company has a loss (—).
- 20.9
- EPSEPS (Earnings Per Share) — the company's net profit over the last 12 months divided by the number of its shares, in the currency of this listing. A negative value (red) means a loss. P/E is the share price divided by EPS.
- 2.91 USD
- |P/B (price to book) — share price ÷ shareholders' equity per share from the latest balance sheet. Graham — as Benjamin Graham counted it: equity without goodwill, other intangible assets and preferred stock, that is tangible book value. He considered up to 1.5 acceptable for a defensive investor (green), or a product P/E × P/B up to 22.5. With negative tangible equity, Graham's P/B is not calculated.
- 1.393.84
- Graham numberGraham number — the highest price Benjamin Graham considered reasonable for a defensive investor: √(22.5 × EPS × tangible book value per share), where 22.5 = P/E 15 × P/B 1.5. A price below it (green) passes both of his limits at once. Not calculated with a loss or negative tangible equity.
- 32.18 USD price 89% above
- ROEROE (return on equity) is net income over the last 12 months divided by average shareholders' equity over those 12 months. It shows how much profit the company earns on every 100 dollars of capital. Consistently above 15% is a sign of a strong business, but a high ROE can also come from heavy debt or small equity after buybacks. One-off gains (sale of a business, revaluation, tax benefit) are excluded; «!» explains why the value differs from the reported one or is unreliable. Companies with negative equity have no ROE.
- 5.6%Reported ROE of 6.9% is inflated by one-off gains (19% of net income): sale of a business or stake, revaluation of investments, a tax benefit. Shown here and used in filters without them.
- Payout ratioPayout ratio — what share of net income the company pays out as dividends. Calculated: dividends paid over the last 12 months ÷ net income for the same 12 months × 100%. Up to 60% — safe margin, 60–90% — borderline, over 90% — dividend at risk of a cut. «Loss» — the company pays without a profit.
- 0%
- FCFFCF (Free Cash Flow) — money left to the company after operating costs and investment in equipment; dividends are safest when paid from it. Calculated: operating cash flow − capital expenditure, over the last 12 months, in the reporting currency.
- 678 M USD
- DebtDebt — all loans and bonds of the company per the latest report (short- and long-term), in the reporting currency. Below — how many years the company would need to repay net debt (debt minus cash) from its free cash flow: net debt ÷ FCF. Up to 3 years — good, 3–6 — moderate, over 6 — high. «Net cash» — net debt is negative.
Debt 2.54 B USD Cash and equivalents 155 M USD Net debt 2.39 B USD FCF 678 M USD Net debt / FCF 3.5 y Total debt / FCF 3.8 y The years shown on the page use net debt: cash on hand can be used to repay debt at any time. - 2.54 B USD3.5 y of FCF
- Earnings, FCF and dividends paid — for the 12 months to 31.07.2026 (the company's latest report).
- Net income
- NAVNAV — net asset value by the balance sheet: the company's assets minus its liabilities, the share of the company's shareholders (without other owners' stakes in its subsidiaries). Shown per share, with P/NAV — how many times the share price exceeds NAV per share (below 1 — the share costs less than its net assets on the balance sheet). Click to see what NAV is made of and its history.
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Exchanges and tickers
| Exchange | Ticker | Currency | Price | Type |
|---|---|---|---|---|
| common stock | ||||
| US USA Stocks | COO primary | USD | 60.72 -1.87% | common stock |
| LSE London Stock Exchange | 0I3I IOB | USD | 61.29 0.00% | common stock |
| MI Borsa Italiana (Milan) | 1COO secondary | EUR | 56.99 +0.72% | common stock |
| MX Mexican Stock Exchange | COO secondary | MXN | 985 +0.00% | common stock |
| XETRA Xetra | CP60 secondary | EUR | 56.96 +0.89% | common stock |
| depositary receipt | ||||
| SA B3 Sao Paulo | C1OO34 | BRL | 30.72 +0.89% | depositary receipt |
Candles
Each candle is one trading day. The thick part runs from the open price to the close price: green — the day closed higher than it opened, red — lower. The thin line runs from the lowest to the highest price of the day. Hover or tap a day to see all four prices.
Dividends
Orange dashed line «ex» — the ex-date: to receive the payment you must hold the shares before this day (shares bought on this day or later come without the dividend). On this day the price often drops by roughly the dividend amount. Blue dashed line «$» — the payment date. Future dates (up to 45 days) are shown on the right on a grey background.
P/E
The share price divided by the company earnings per share for the last 12 months (EPS). It shows how many years the company would need to earn its current profit to «pay back» the price: a lower P/E means the stock is cheaper relative to earnings. The line has its own scale on the left.
For some companies earnings come from their quarterly reports: on the day of a new report P/E jumps (a purple tick at the bottom of the chart), between reports it changes only with the price. For others P/E uses current earnings, so before the latest report it is approximate. If earnings are negative, P/E is not shown.
My position
Visible only to you and only if this stock is among your open portfolio positions (purchases in the same currency as the chart exchange). From each purchase date there is a dashed line at the purchase price, and between it and each day close price — an area: green if the position is in profit, red if at a loss. If you sold part, the remainder is shown: a sale writes off the earliest purchases first. The day tooltip shows how many shares were in the position and the gain or loss in money and %.
Payout yield
The blue dashed curve with its own % scale on the left: for each day — the last payment amount divided by that day close price. That is, what percentage of the share price one payment makes: the price rises — the percentage falls, and vice versa; when the company changes the payment, the curve moves to the new amount. The annual yield is roughly this percentage times the number of payments per year.
Above each «$» mark — the percentage of that payment relative to the price on the payment day (for future ones — relative to the last price, marked «≈»). Only payments in the chart exchange currency are counted.
Dividends
| Ex-date | Payment | Amount | % | Type | Ticker |
|---|---|---|---|---|---|
| 2023-07-26 | — | 0.0300 USD | 0.0/0.0 % | — | LSE:0I3I |
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| Blackrock Inc. | 7.9% | 15.03 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.71% | 12.76 M | 2026-06-30 |
| State Street Corporation | 4.68% | 8.89 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.56% | 8.67 M | 2026-06-30 |
| T. Rowe Price Investment… | 3.91% | 7.43 M | 2026-06-30 |
| Browning West Lp | 3.78% | 7.2 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.26% | 6.19 M | 2026-06-30 |
| Price (T.Rowe) Associate… | 2.93% | 5.58 M | 2026-06-30 |
| Kayne Anderson Rudnick I… | 2.86% | 5.43 M | 2026-06-30 |
| Geode Capital Management… | 2.82% | 5.36 M | 2026-06-30 |
| Franklin Resources, Inc. | 2.68% | 5.1 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.66% | 5.06 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.35% | 4.47 M | 2026-06-30 |
| T. Rowe Price Mid-Cap Gr… | 2.04% | 3.88 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.49% | 2.83 M | 2026-06-30 |
| Invesco Exchange-Traded… | 1.47% | 2.79 M | 2026-08-31 |
| T. Rowe Price Mid-Cap Va… | 1.45% | 2.76 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.37% | 2.6 M | 2026-08-31 |
| JANUS INVESTMENT FUND-Ja… | 1.33% | 2.52 M | 2026-06-30 |
| Fidelity Concord Street… | 1.33% | 2.52 M | 2026-07-31 |
| WEISS ROBERT S (Director… | ≈0.29% | 550 459 | 2026-04-01 |
| WHITE ALBERT G III (Chie… | ≈0.13% | 245 072 | 2026-01-08 |
| MCBRIDE DANIEL G (Chief… | ≈0.09% | 163 848 | 2026-01-08 |
| SHEFFIELD HOLLY R (Offic… | ≈0.02% | 43 261 | 2026-01-08 |
| JAY COLLEEN E (Director) | ≈0.02% | 39 907 | 2026-04-01 |
| KOZY WILLIAM A (Director… | ≈0.02% | 31 149 | 2025-04-01 |
| KURZIUS LAWRENCE ERIK (D… | ≈0.02% | 31 099 | 2026-09-16 |
| ANDREWS BRIAN G (Chief F… | ≈0.02% | 30 728 | 2026-01-08 |
| WARNER GERARD H, III (Of… | ≈0.01% | 23 852 | 2026-01-08 |
| ROSEBROUGH WALTER M JR (… | — | — | 2026-09-14 |
